ZA9811461B - New formulation - Google Patents
New formulationInfo
- Publication number
- ZA9811461B ZA9811461B ZA9811461A ZA9811461A ZA9811461B ZA 9811461 B ZA9811461 B ZA 9811461B ZA 9811461 A ZA9811461 A ZA 9811461A ZA 9811461 A ZA9811461 A ZA 9811461A ZA 9811461 B ZA9811461 B ZA 9811461B
- Authority
- ZA
- South Africa
- Prior art keywords
- new formulation
- formulation
- new
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9704833A SE9704833D0 (sv) | 1997-12-22 | 1997-12-22 | New formulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA9811461B true ZA9811461B (en) | 1999-06-22 |
Family
ID=20409536
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA9811461A ZA9811461B (en) | 1997-12-22 | 1998-12-14 | New formulation |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1043973A1 (et) |
| JP (1) | JP2001526210A (et) |
| KR (1) | KR20010024789A (et) |
| CN (1) | CN1283106A (et) |
| AR (1) | AR017220A1 (et) |
| AU (1) | AU1993599A (et) |
| BR (1) | BR9813811A (et) |
| CA (1) | CA2315782A1 (et) |
| EE (1) | EE200000388A (et) |
| HU (1) | HUP0102365A3 (et) |
| ID (1) | ID26945A (et) |
| IL (1) | IL136880A0 (et) |
| NO (1) | NO20003220L (et) |
| NZ (1) | NZ505073A (et) |
| PL (1) | PL341361A1 (et) |
| SE (1) | SE9704833D0 (et) |
| SK (1) | SK9532000A3 (et) |
| TR (1) | TR200001977T2 (et) |
| WO (1) | WO1999032089A1 (et) |
| ZA (1) | ZA9811461B (et) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9902674D0 (sv) * | 1999-07-12 | 1999-07-12 | Astra Ab | New composition |
| SE0000332D0 (sv) * | 2000-01-31 | 2000-01-31 | Astrazeneca Ab | New use |
| US6858593B2 (en) | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
| US6759398B2 (en) | 2000-08-05 | 2004-07-06 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative |
| US6777400B2 (en) | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
| GB0019172D0 (en) | 2000-08-05 | 2000-09-27 | Glaxo Group Ltd | Novel compounds |
| US6750210B2 (en) | 2000-08-05 | 2004-06-15 | Smithkline Beecham Corporation | Formulation containing novel anti-inflammatory androstane derivative |
| US6858596B2 (en) | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivative |
| US6777399B2 (en) | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
| US6787532B2 (en) * | 2000-08-05 | 2004-09-07 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivatives |
| SE0100901D0 (sv) * | 2001-03-15 | 2001-03-15 | Astrazeneca Ab | New composition |
| UA77656C2 (en) | 2001-04-07 | 2007-01-15 | Glaxo Group Ltd | S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent |
| GB2389530B (en) | 2002-06-14 | 2007-01-10 | Cipla Ltd | Pharmaceutical compositions |
| JPWO2005018607A1 (ja) * | 2003-08-20 | 2007-11-01 | 味の素株式会社 | 溶解性を改善した医薬品製剤 |
| US8497258B2 (en) | 2005-11-12 | 2013-07-30 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
| CN100579510C (zh) * | 2006-04-13 | 2010-01-13 | 新疆维吾尔自治区包虫病临床研究所 | 新型前体胶束制剂及其生产方法 |
| US20090123390A1 (en) | 2007-11-13 | 2009-05-14 | Meritage Pharma, Inc. | Compositions for the treatment of gastrointestinal inflammation |
| ES2729925T3 (es) | 2007-11-13 | 2019-11-07 | Meritage Pharma Inc | Composiciones de corticosteroides |
| EP2334285A1 (en) * | 2008-09-12 | 2011-06-22 | Critical Pharmaceuticals Limited | Improvements in the absorption of therapeutic agents across mucosal membranes or the skin |
| CN101982168B (zh) * | 2010-11-02 | 2012-05-23 | 山东大学 | 一种槲皮素纳米胶束制剂及其制备方法 |
| CN102793678B (zh) * | 2011-05-26 | 2017-06-30 | 邓世明 | 一种不含吐温的多烯紫杉醇注射剂的制备方法 |
| DE102011108948A1 (de) * | 2011-07-29 | 2013-01-31 | Achim Göpferich | Wässrige, kolloidale Lösungen von lipophilen Substanzen,insbesondere Arzneistofflösungen |
| JP5456802B2 (ja) * | 2012-01-23 | 2014-04-02 | 株式会社Ｃａｃ | 細胞遊走促進剤及び創傷治療用の経皮吸収剤 |
| WO2015008301A1 (en) * | 2013-07-17 | 2015-01-22 | Council Of Scientific & Industrial Research | Pharmaceutical composition for the treatment of diminution of bone tissue |
| US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
| KR20180126582A (ko) | 2016-04-01 | 2018-11-27 | 쎄러퓨틱스엠디, 인코퍼레이티드 | 스테로이드 호르몬 약제학적 조성물 |
| US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
| KR102086316B1 (ko) * | 2019-09-09 | 2020-03-09 | 한국콜마주식회사 | 경피흡수성이 우수한 화장료 조성물 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0179583A1 (en) * | 1984-10-04 | 1986-04-30 | Merck & Co. Inc. | A system for enhancing the water dissolution rate and solubility of poorly soluble drugs |
| US4994439A (en) * | 1989-01-19 | 1991-02-19 | California Biotechnology Inc. | Transmembrane formulations for drug administration |
| AR002009A1 (es) * | 1994-12-22 | 1998-01-07 | Astra Ab | Composicion farmaceutica, procedimiento para la manufactura de un polvo de proliposoma como el utilizado en dicha composicion, procedimiento para lamanufactura de dicha composicion, uso de dicha composicion farmaceutica en la manufactura de un medicamento y dispositivo inhalador de polvo seco. |
-
1997
- 1997-12-22 SE SE9704833A patent/SE9704833D0/xx unknown
-
1998
- 1998-12-14 ZA ZA9811461A patent/ZA9811461B/xx unknown
- 1998-12-17 AR ARP980106453A patent/AR017220A1/es not_active Application Discontinuation
- 1998-12-22 BR BR9813811-1A patent/BR9813811A/pt not_active IP Right Cessation
- 1998-12-22 KR KR1020007006879A patent/KR20010024789A/ko not_active Application Discontinuation
- 1998-12-22 CA CA002315782A patent/CA2315782A1/en not_active Abandoned
- 1998-12-22 PL PL98341361A patent/PL341361A1/xx unknown
- 1998-12-22 TR TR2000/01977T patent/TR200001977T2/xx unknown
- 1998-12-22 CN CN98812507A patent/CN1283106A/zh active Pending
- 1998-12-22 HU HU0102365A patent/HUP0102365A3/hu unknown
- 1998-12-22 EP EP98964662A patent/EP1043973A1/en not_active Withdrawn
- 1998-12-22 IL IL13688098A patent/IL136880A0/xx unknown
- 1998-12-22 WO PCT/SE1998/002426 patent/WO1999032089A1/en not_active Application Discontinuation
- 1998-12-22 JP JP2000525082A patent/JP2001526210A/ja active Pending
- 1998-12-22 NZ NZ505073A patent/NZ505073A/xx unknown
- 1998-12-22 AU AU19935/99A patent/AU1993599A/en not_active Abandoned
- 1998-12-22 SK SK953-2000A patent/SK9532000A3/sk unknown
- 1998-12-22 ID IDW20001131A patent/ID26945A/id unknown
- 1998-12-22 EE EEP200000388A patent/EE200000388A/et unknown
-
2000
- 2000-06-21 NO NO20003220A patent/NO20003220L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0102365A2 (hu) | 2001-11-28 |
| JP2001526210A (ja) | 2001-12-18 |
| NO20003220L (no) | 2000-08-22 |
| WO1999032089A1 (en) | 1999-07-01 |
| NZ505073A (en) | 2002-09-27 |
| AU1993599A (en) | 1999-07-12 |
| EE200000388A (et) | 2002-02-15 |
| SE9704833D0 (sv) | 1997-12-22 |
| BR9813811A (pt) | 2000-10-03 |
| EP1043973A1 (en) | 2000-10-18 |
| CA2315782A1 (en) | 1999-07-01 |
| HUP0102365A3 (en) | 2002-01-28 |
| CN1283106A (zh) | 2001-02-07 |
| KR20010024789A (ko) | 2001-03-26 |
| TR200001977T2 (tr) | 2000-12-21 |
| IL136880A0 (en) | 2001-06-14 |
| ID26945A (id) | 2001-02-22 |
| SK9532000A3 (en) | 2000-11-07 |
| PL341361A1 (en) | 2001-04-09 |
| AR017220A1 (es) | 2001-08-22 |
| NO20003220D0 (no) | 2000-06-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL135295A0 (en) | 2-methyl-thieno-benzodiazepine formulation | |
| GB9715751D0 (en) | Formulations | |
| ZA9811461B (en) | New formulation | |
| GB9726916D0 (en) | Nasal formulation | |
| DE69840493D1 (en) | Tionseinlage | |
| ZA9710601B (en) | Novel formulation | |
| DE69810944D1 (en) | Hydroperoxidzersetzungsverfahren | |
| HK1026429A1 (en) | New formulation | |
| ZA984230B (en) | Carotenoid formulation | |
| GB9724544D0 (en) | Novel Formulation | |
| ZA9810184B (en) | New phenyl-alkyl-imidazoles | |
| GB9727518D0 (en) | Use | |
| EP0968655A4 (en) | SPREAD | |
| DE69801658D1 (en) | Polyurethanhartschaumstoffe | |
| DE59708342D1 (en) | Basophilen-degranulationstest | |
| ZA9810773B (en) | Revitalisation formulation | |
| GB9706957D0 (en) | Formulation | |
| GB9810180D0 (en) | Novel formulation | |
| GB9615628D0 (en) | Formulation | |
| DE69829970D1 (en) | Implantsystem | |
| DE59806884D1 (en) | Dexamethason-gel | |
| GB2330196B (en) | Starcloth | |
| GB9725275D0 (en) | Formulation | |
| GB9721807D0 (en) | Formulation | |
| GB9704521D0 (en) | Formulations |